SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001013762-23-002005
Filing Date
2023-10-05
Accepted
2023-10-05 08:15:11
Documents
22
Period of Report
2023-10-04
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea186346-8k_hoththera.htm   iXBRL 8-K 25181
2 ARTICLES OF INCORPORATION OF MERVEILLE.AI ea186346ex3-1_hoththera.htm EX-3.1 7749
3 GRAPHIC ex3-1_001.jpg GRAPHIC 2372488
4 GRAPHIC ex3-1_002.jpg GRAPHIC 187140
5 GRAPHIC ex3-1_003.jpg GRAPHIC 253988
6 GRAPHIC ex3-1_004.jpg GRAPHIC 212776
7 GRAPHIC ex3-1_005.jpg GRAPHIC 35513
8 GRAPHIC ex3-1_006.jpg GRAPHIC 157172
9 GRAPHIC ex3-1_007.jpg GRAPHIC 206408
10 GRAPHIC ex3-1_008.jpg GRAPHIC 247161
11 GRAPHIC ex3-1_009.jpg GRAPHIC 204842
  Complete submission text file 0001013762-23-002005.txt   5545979

Data Files

Seq Description Document Type Size
12 XBRL SCHEMA FILE hoth-20231004.xsd EX-101.SCH 3039
13 XBRL LABEL FILE hoth-20231004_lab.xml EX-101.LAB 34240
14 XBRL PRESENTATION FILE hoth-20231004_pre.xml EX-101.PRE 22375
16 EXTRACTED XBRL INSTANCE DOCUMENT ea186346-8k_hoththera_htm.xml XML 3406
Mailing Address 1 ROCKEFELLER PLAZA, SUITE 1039 NEW YORK NY 10020
Business Address 1 ROCKEFELLER PLAZA, SUITE 1039 NEW YORK NY 10020 551-578-2261
Hoth Therapeutics, Inc. (Filer) CIK: 0001711786 (see all company filings)

IRS No.: 821553794 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38803 | Film No.: 231309859
SIC: 2834 Pharmaceutical Preparations